ALPK1

Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity

Ribas, A. et al. SD-101 in combination with pembrolizumab in advanced melanoma: results of a phase Ib, multicenter study. Cancer…

أكمل القراءة »